Twin Tree Management, LP Cure Vac N.V. Transaction History
Twin Tree Management, LP
- $51.9 Billion
- Q1 2025
A detailed history of Twin Tree Management, LP transactions in Cure Vac N.V. stock. As of the latest transaction made, Twin Tree Management, LP holds 44,200 shares of CVAC stock, worth $198,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,200Holding current value
$198,016% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CVAC
# of Institutions
94Shares Held
10.7MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$10.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.82MShares$8.14 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$7.03 Million10.6% of portfolio
-
Ubs Group Ag843KShares$3.78 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0308KShares$1.38 Million0.08% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $840M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...